Skip to main content
. 2020 Jul 9;6(9):1416–1421. doi: 10.1001/jamaoncol.2020.2394

Figure. Disease-Free Survival of the Study Patients Based on Univariable Analysis According to Treatment Group.

Figure.

A, Neoadjuvant fluorouracil chemoradiotherapy (CRT). B, Neoadjuvant fluorouracil-oxaliplatin CRT, as shown in eTable 2 in Supplement 2. C, Adjuvant fluorouracil chemotherapy (CT) (complete vs near complete, P = .66; complete vs incomplete, P = .69). D, Adjuvant fluorouracil-oxaliplatin CT (complete vs near complete, P = .55; complete vs incomplete P = .65). Percentages refer to 3-year disease-free survival.